In its third-quarter conference call last week, Ciphergen laid out a three-pronged marketing strategy for 2004: a push to get customers to automate existing systems, continued expansion of biomarker research into the clinical space, and an aggressive entry into the diagnostics market.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.